Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB

Multiple Myeloma (MM) is a malignant neoplasm arising from a single plasma cell clone. It mainly affects older people. It forms localised osteolytic lesions. It secretes a single monoclonal immunoglobulin of constant isotype with light-chain restriction (paraprotein). MM cells may express, an adhesi...

Full description

Bibliographic Details
Main Authors: Ashok Kumar Kapoor, Supriya Mehrotra, Rajesh Kumar Srivastava
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2019-04-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/12763/40096_CE[Ra1]_F(AC)_PF1(AB_KM_SL)_PN(SL).pdf
id doaj-07ce3fc33941496d8a02c65b086b4aae
record_format Article
spelling doaj-07ce3fc33941496d8a02c65b086b4aae2020-11-25T03:08:07ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2019-04-01134ED04ED0510.7860/JCDR/2019/40096.12763Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TBAshok Kumar Kapoor0Supriya Mehrotra1Rajesh Kumar Srivastava2Pathologist, Department of Pathology, RML Mehrotra Pathology Pvt. Ltd, Nirala Nagar, Lucknow, Uttar Pradesh, India.Pathologist, Department of Pathology, RML Mehrotra Pathology Pvt. Ltd, Nirala Nagar, Lucknow, Uttar Pradesh, India.Senior Technologist, Department of Pathology, RML Mehrotra Pathology Pvt. Ltd, Nirala Nagar, Lucknow, Uttar Pradesh, India.Multiple Myeloma (MM) is a malignant neoplasm arising from a single plasma cell clone. It mainly affects older people. It forms localised osteolytic lesions. It secretes a single monoclonal immunoglobulin of constant isotype with light-chain restriction (paraprotein). MM cells may express, an adhesion molecule. This molecule is not present on normal plasma cell. In addition, immunoglobulin light-chain may be detected in urine (Bence jones proteins). Rarely, one of the isotypes may switch to another type during high-dose chemotherapy. In addition, Isotype Switch (IS) may occur spontaneously without any treatment. The present case relates about an 87-year-old man who complained of pain in dorsal thoracic region. X-ray examination showed fractures of thoracic vertebra eighth to tenth. Sternal puncture was done. Bone marrow examination showed large number of plasmacytoid cells. Moreover, serum protein electrophoresis revealed moderately raised M band proteins in gamma globulin region (M band protein concentration was 2.03 gm/dL). The patient was diagnosed as a case of MM. Initially, he was treated with Thalidomide 100 mg daily for one month. Later, he was treated with Lenalidomide 10 mg daily for 30 days followed by a drug-free period of 15 days. After eight cycles of Lenalidomide therapy light-chain IS was detected. Initially, tumour produced lambda (λ) light-chain for one year as seen in first, second and third serum specimens. Later, light-chain switch was detected in fourth serum specimen from lambda (λ) to kappa (k) light-chain. IS was accompanied with high level of M band proteins (5.4 gm/dL). In addition, the patient developed Miliary Tuberculosis. Subsequently, the patient was treated with Phaglomide (Pomalidomide) instead of Lenalidomide.https://jcdr.net/articles/PDF/12763/40096_CE[Ra1]_F(AC)_PF1(AB_KM_SL)_PN(SL).pdfcd56kappa light-chainplasmacytoma lambda light-chain
collection DOAJ
language English
format Article
sources DOAJ
author Ashok Kumar Kapoor
Supriya Mehrotra
Rajesh Kumar Srivastava
spellingShingle Ashok Kumar Kapoor
Supriya Mehrotra
Rajesh Kumar Srivastava
Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB
Journal of Clinical and Diagnostic Research
cd56
kappa light-chain
plasmacytoma lambda light-chain
author_facet Ashok Kumar Kapoor
Supriya Mehrotra
Rajesh Kumar Srivastava
author_sort Ashok Kumar Kapoor
title Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB
title_short Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB
title_full Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB
title_fullStr Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB
title_full_unstemmed Immunoglobulin Light-Chain Isotype Switch (IS) during Lenalidomide Therapy in Multiple Myeloma and its Association with Increased M Protein Production and Miliary TB
title_sort immunoglobulin light-chain isotype switch (is) during lenalidomide therapy in multiple myeloma and its association with increased m protein production and miliary tb
publisher JCDR Research and Publications Private Limited
series Journal of Clinical and Diagnostic Research
issn 2249-782X
0973-709X
publishDate 2019-04-01
description Multiple Myeloma (MM) is a malignant neoplasm arising from a single plasma cell clone. It mainly affects older people. It forms localised osteolytic lesions. It secretes a single monoclonal immunoglobulin of constant isotype with light-chain restriction (paraprotein). MM cells may express, an adhesion molecule. This molecule is not present on normal plasma cell. In addition, immunoglobulin light-chain may be detected in urine (Bence jones proteins). Rarely, one of the isotypes may switch to another type during high-dose chemotherapy. In addition, Isotype Switch (IS) may occur spontaneously without any treatment. The present case relates about an 87-year-old man who complained of pain in dorsal thoracic region. X-ray examination showed fractures of thoracic vertebra eighth to tenth. Sternal puncture was done. Bone marrow examination showed large number of plasmacytoid cells. Moreover, serum protein electrophoresis revealed moderately raised M band proteins in gamma globulin region (M band protein concentration was 2.03 gm/dL). The patient was diagnosed as a case of MM. Initially, he was treated with Thalidomide 100 mg daily for one month. Later, he was treated with Lenalidomide 10 mg daily for 30 days followed by a drug-free period of 15 days. After eight cycles of Lenalidomide therapy light-chain IS was detected. Initially, tumour produced lambda (λ) light-chain for one year as seen in first, second and third serum specimens. Later, light-chain switch was detected in fourth serum specimen from lambda (λ) to kappa (k) light-chain. IS was accompanied with high level of M band proteins (5.4 gm/dL). In addition, the patient developed Miliary Tuberculosis. Subsequently, the patient was treated with Phaglomide (Pomalidomide) instead of Lenalidomide.
topic cd56
kappa light-chain
plasmacytoma lambda light-chain
url https://jcdr.net/articles/PDF/12763/40096_CE[Ra1]_F(AC)_PF1(AB_KM_SL)_PN(SL).pdf
work_keys_str_mv AT ashokkumarkapoor immunoglobulinlightchainisotypeswitchisduringlenalidomidetherapyinmultiplemyelomaanditsassociationwithincreasedmproteinproductionandmiliarytb
AT supriyamehrotra immunoglobulinlightchainisotypeswitchisduringlenalidomidetherapyinmultiplemyelomaanditsassociationwithincreasedmproteinproductionandmiliarytb
AT rajeshkumarsrivastava immunoglobulinlightchainisotypeswitchisduringlenalidomidetherapyinmultiplemyelomaanditsassociationwithincreasedmproteinproductionandmiliarytb
_version_ 1724667408194469888